Whole-cell in vitro screening for gametocytocidal compounds

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Murray CJ, Rosenfeld LC, Lim SS et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet379(9814),413–431 (2012).
  MedlineGoogle Scholar
• 2  Aly AS, Vaughan AM, Kappe SH. Malaria parasite development in the mosquito and infection of the mammalian host. Annu. Rev. Microbiol.63,195–221 (2009).
  Medline CASGoogle Scholar
• 3  Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate. Nat. Rev. Microbiol.7(12),864–874 (2009).
  Medline CASGoogle Scholar
• 4  Alonso PL, Brown G, Arevalo-Herrera M et al. A research agenda to underpin malaria eradication. PLoS Medicine8(1),e1000406 (2011).
  MedlineGoogle Scholar
• 5  White NJ. The role of anti-malarial drugs in eliminating malaria. Malar. J.7(Suppl. 1),S8 (2008).
  MedlineGoogle Scholar
• 6  Hallett RL, Sutherland CJ, Alexander N et al. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob. Agents Chemother.48(10),3940–3943 (2004).
  Medline CASGoogle Scholar
• 7  Burrows JN, Leroy D, Lotharius J, Waterson D. Challenges in antimalarial drug discovery. Future Med. Chem.3(11),1401–1412 (2012).
  Google Scholar
• 8  Sinden RE, Smalley ME. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology79(2),277–296 (1979).
  Medline CASGoogle Scholar
• 9  Lensen A, Bril A, Van De Vegte M, Van Gemert GJ, Eling W, Sauerwein R. Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. Exp. Parasitol.91(1),101–103 (1999).
  Medline CASGoogle Scholar
• 10  Carter R, Miller LH. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull. World Health Organ.57(Suppl. 1),37–52 (1979).
  MedlineGoogle Scholar
• 11  Farfour E, Charlotte F, Settegrana C, Miyara M, Buffet P. The extravascular compartment of the bone marrow: a niche for Plasmodium falciparum gametocyte maturation? Malar. J.11(1),285 (2012).
  MedlineGoogle Scholar
• 12  Alano P. Plasmodium falciparum gametocytes: still many secrets of a hidden life. Mol. Microbiol.66(2),291–302 (2007).
  Medline CASGoogle Scholar
• 13  Silvestrini F, Tiburcio M, Bertuccini L, Alano P. Differential adhesive properties of sequestered asexual and sexual stages of Plasmodium falciparum on human endothelial cells are tissue independent. PLoS ONE7(2),e31567 (2012).
  Medline CASGoogle Scholar
• 14  Aingaran M, Zhang R, Law SK et al. Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum. Cell. Microbiol.14(7),983–993 (2012).
  Medline CASGoogle Scholar
• 15  Bousema T, Okell L, Shekalaghe S et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar. J.9,136 (2010).
  MedlineGoogle Scholar
• 16  Karl S, Gurarie D, Zimmerman PA, King CH, St Pierre TG, Davis TM. A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS ONE6(6),e20805 (2011).
  Medline CASGoogle Scholar
• 17  Chotivanich K, Sattabongkot J, Udomsangpetch R et al. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob. Agents Chemother.50(6),1927–1930 (2006).
  Medline CASGoogle Scholar
• 18  Lanners HN. Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum. Parasitol. Res.77(6),478–481 (1991).
  Medline CASGoogle Scholar
• 19  Bousema JT, Schneider P, Gouagna LC et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J. Infect. Dis.193(8),1151–1159 (2006).
  Medline CASGoogle Scholar
• 20  Shekalaghe S, Drakeley C, Gosling R et al. Primaquine clears submicroscopic Plasmodium falciparumgametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE2(10),e1023 (2007).
  MedlineGoogle Scholar
• 21  O’Brien C, Henrich PP, Passi N, Fidock DA. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr. Opin. Infect. Dis.24(6),570–577 (2011).
  MedlineGoogle Scholar
• 22  Hedrick PW. Population genetics of malaria resistance in humans. Heredity107(4),283–304 (2011).
  Medline CASGoogle Scholar
• 23  Kiszewski AE. Blocking Plasmodium falciparum malaria transmission with drugs: the gametocytocidal and sporontocidal properties of current and prospective antimalarials. Pharmaceuticals4,44–68 (2011).
  CASGoogle Scholar
• 24  Van Pelt-Koops JC, Pett HE, Graumans W et al. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob. Agents Chemother.56(7),3544–3548 (2012).
  Medline CASGoogle Scholar
• 25  Aminake MN, Schoof S, Sologub L et al. Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast. Antimicrob. Agents Chemother.55(4),1338–1348 (2011).
  Medline CASGoogle Scholar
• 26  Saenz FE, Mutka T, Udenze K, Oduola AM, Kyle DE. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodiumin vivo and in vitro. Antimicrob. Agents Chemother.56(9),4685–4692 (2012).
  Medline CASGoogle Scholar
• 27  Avery VM, Camp D, Carroll AR, Jenkins ID, Quinn RJ. The identification of bioactive natural products by high throughput screening (HTS). In: Comprehensive natural products II: chemistry and biology. Mander L, Lui HW (Eds). Elsevier, Oxford, 177–203 (2010).
  Google Scholar
• 28  Guiguemde WA, Shelat AA, Bouck D et al. Chemical genetics of Plasmodium falciparum. Nature465(7296),311–315 (2010).▪ The St. Jude Children’s Hospital collection of 309,474 compounds was tested against the 3D7 and K1 strains of Plasmodium falciparum, giving 1,134 validate antimalarial hits.
  Medline CASGoogle Scholar
• 29  Plouffe D, Brinker A, Mcnamara C et al.In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl Acad. Sci. USA105(26),9059–9064 (2008).
  Medline CASGoogle Scholar
• 30  Gamo FJ, Sanz LM, Vidal J et al. Thousands of chemical starting points for antimalarial lead identification. Nature465(7296),305–310 (2010).▪ Reports the screening of the 1,986,056-compound GlaxoSmithKline TCAMS library, which yielded 13,533 confirmed hits with antimalarial activity.
  Medline CASGoogle Scholar
• 31  Rottmann M, Mcnamara C, Yeung BK et al. Spiroindolones, a potent compound class for the treatment of malaria. Science329(5996),1175–1180 (2010).▪ The report describes the screening of the 12,000-compound library from NITD, and introduces spiroindolones, a new class of potent antimalarial compounds.
  Medline CASGoogle Scholar
• 32  Trager W, Jensen JB. Human malaria parasites in continuous culture. Science193(4254),673–675 (1976).
  Medline CASGoogle Scholar
• 33  Smalley ME. Plasmodium falciparum gametocytogenesis in vitro. Nature264(5583),271–272 (1976).
  Medline CASGoogle Scholar
• 34  Bruce MC, Alano P, Duthie S, Carter R. Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development. Parasitology100(Pt 2),191–200 (1990).
  MedlineGoogle Scholar
• 35  Silvestrini F, Alano P, Williams JL. Commitment to the production of male and female gametocytes in the human malaria parasite Plasmodium falciparum. Parasitology121(Pt 5),465–471 (2000).
  MedlineGoogle Scholar
• 36  Baker DA. Malaria gametocytogenesis. Mol. Biochem. Parasitol.172(2),57–65 (2010).
  Medline CASGoogle Scholar
• 37  Ifediba T, Vanderberg JP. Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature294(5839),364–366 (1981).
  Medline CASGoogle Scholar
• 38  Bennett TN, Kosar AD, Roepe PD. Plasmodium falciparum strain GC-03 exhibits hyper-gametocytogenesis in partially hemoglobin depleted red blood cells. Mol. Biochem. Parasitol.139(2),261–265 (2005).
  Medline CASGoogle Scholar
• 39  Schneweis S, Maier WA, Seitz HM. Haemolysis of infected erythrocytes--a trigger for formation of Plasmodium falciparum gametocytes? Parasitol. Res.77(5),458–460 (1991).
  Medline CASGoogle Scholar
• 40  Roncales M, Vidal-Mas J, Leroy D, Herreros E. Comparison and optimization of different methods for the in vitro production of Plasmodium falciparum gametocytes. J. Parasitol. Res.927148 (2012).
  MedlineGoogle Scholar
• 41  Trager W, Gill GS, Lawrence C, Nagel RL. Plasmodium falciparum: enhanced gametocyte formation in vitro in reticulocyte-rich blood. Exp. Parasitol.91(2),115–118 (1999).
  Medline CASGoogle Scholar
• 42  Dyer M, Day KP. Regulation of the rate of asexual growth and commitment to sexual development by diffusible factors from in vitro cultures of Plasmodium falciparum. Am. J. Trop. Med. Hyg.68(4),403–409 (2003).
  MedlineGoogle Scholar
• 43  Williams JL. Stimulation of Plasmodium falciparum gametocytogenesis by conditioned medium from parasite cultures. Am. J. Trop. Med. Hyg.60(1),7–13 (1999).
  Medline CASGoogle Scholar
• 44  Buckling A, Ranford-Cartwright LC, Miles A, Read AF. Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology118(Pt 4),339–346 (1999).
  Medline CASGoogle Scholar
• 45  Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodiumvivax gametocytes in relation to malaria control and elimination. Clin. Microbiol. Rev.24(2),377–410 (2011).
  MedlineGoogle Scholar
• 46  Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol.65(3),418–420 (1979).
  Medline CASGoogle Scholar
• 47  Carter R, Ranford-Cartwright L, Alano P. The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies. Methods Mol. Biol.21,67–88 (1993).
  Medline CASGoogle Scholar
• 48  Chevalley S, Coste A, Lopez A, Pipy B, Valentin A. Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malar. J.9,49 (2010).▪ Flow cytometry was applied to assess the activity of reference compounds on late-stage P. falciparum gametocytes.
  MedlineGoogle Scholar
• 49  Buchholz K, Burke TA, Williamson KC, Wiegand RC, Wirth DF, Marti M. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J. Infect. Dis.203(10),1445–1453 (2011).▪▪ Describes a flow-cytometry-based assay for testing compound activity on sexually committed P. falciparum asexual stages and early gametocytes.
  MedlineGoogle Scholar
• 50  Tanaka TQ, Williamson KC. A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol. Biochem. Parasitol.177(2),160–163 (2011).▪▪ Describes a screening method on late-stage P. falciparum gametocytes using alamarBlue®, a fluorescent oxidoreduction indicator.
  Medline CASGoogle Scholar
• 51  Lelievre J, Almela MJ, Lozano S et al. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence ‘transmission blocking’ assay. PLoS ONE7(4),e35019 (2012).▪▪ Describes an ATP-bioluminesce assay for late-stage P. falciparum gametocytes.
  Medline CASGoogle Scholar
• 52  Fivelman QL, Mcrobert L, Sharp S et al. Improved synchronous production of Plasmodium falciparum gametocytes in vitro. Mol. Biochem. Parasitol.154(1),119–123 (2007).
  Medline CASGoogle Scholar
• 53  Peatey CL, Spicer TP, Hodder PS, Trenholme KR, Gardiner DL. A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol. Biochem. Parasitol.180(2),127–131 (2011).▪▪ Describes an ATP-bioluminesce assay for late-stage P. falciparum gametocytes.
  Medline CASGoogle Scholar
• 54  Adjalley SH, Johnston GL, Li T et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc. Natl Acad. Sci. USA108(47),E1214–E1223 (2011).▪▪ Describes a stage-specific assay for measuring the gametocytocidal activity of compounds over time, based on the expression of luciferase in transgenic parasites.
  MedlineGoogle Scholar
• 55  Jungery M, Pasvol G, Newbold CI, Weatherall DJ. A lectin-like receptor is involved in invasion of erythrocytes by Plasmodium falciparum. Proc. Natl Acad. Sci. USA80(4),1018–1022 (1983).
  Medline CASGoogle Scholar
• 56  Ponnudurai T, Lensen AH, Meis JF, Meuwissen JH. Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology93( Pt 2),263–274 (1986).
  MedlineGoogle Scholar
• 57  Karl S, Davis TM, St Pierre TG. Parameterization of high magnetic field gradient fractionation columns for applications with Plasmodium falciparum infected human erythrocytes. Malar. J.9,116 (2010).
  MedlineGoogle Scholar
• 58  Kariuki MM, Kiaira JK, Mulaa FK, Mwangi JK, Wasunna MK, Martin SK. Plasmodium falciparum: purification of the various gametocyte developmental stages from in vitro-cultivated parasites. Am. J. Trop. Med. Hyg.59(4),505–508 (1998).
  Medline CASGoogle Scholar
• 59  Carter EH, Suhrbier A, Beckers PJ, Sinden RE. The in vitro cultivation of P. falciparum ookinetes, and their enrichment on Nycodenz density gradients. Parasitology95(Pt 1),25–30 (1987).
  MedlineGoogle Scholar
• 60  Smalley ME. Plasmodium falciparum gametocytes: The effect of chloroquine on their development. Trans. R. Soc. Trop. Med. Hyg.71(6),526–529 (1977).
  Medline CASGoogle Scholar
• 61  Smalley ME, Sinden RE. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology74(1),1–8 (1977).
  Medline CASGoogle Scholar
• 62  Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother.16(6),710–718 (1979).
  Medline CASGoogle Scholar
• 63  Makler MT, Ries JM, Williams JA et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg.48(6),739–741 (1993).
  Medline CASGoogle Scholar
• 64  Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob. Agents Chemother.51(6),1926–1933 (2007).
  Medline CASGoogle Scholar
• 65  Baniecki ML, Wirth DF, Clardy J. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob. Agents Chemother.51(2),716–723 (2007).
  Medline CASGoogle Scholar
• 66  Cervantes S, Prudhomme J, Carter D et al. High-content live cell imaging with RNA probes: advancements in high-throughput antimalarial drug discovery. BMC Cell Biol.10,45 (2009).
  MedlineGoogle Scholar
• 67  Duffy S, Avery VM. Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening. Am. J. Trop. Med. Hyg.86(1),84–92 (2012).
  Medline CASGoogle Scholar
• 68  Lucumi E, Darling C, Jo H et al. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay. Antimicrob. Agents Chemother.54(9),3597–3604 (2010).
  Medline CASGoogle Scholar
• 69  Che P, Cui L, Kutsch O, Li Q. Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery. Assay Drug Dev. Technol.10(1),61–68 (2012).
  Medline CASGoogle Scholar
• 70  Benoit-Vical F, Lelievre J, Berry A et al. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother.51(4),1463–1472 (2007).
  Medline CASGoogle Scholar
• 71  Ferrer P, Tripathi AK, Clark MA, Hand CC, Rienhoff HY Jr, Sullivan DJ Jr. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model. PLoS ONE7(5),e37171 (2012).
  Medline CASGoogle Scholar
• 72  Engelbrecht D, Coetzer TL. The walking dead: is hydroethidine a suitable viability dye for intra-erythrocytic Plasmodium falciparum? Parasitol. Int.61(4),731–734 (2012).
  Medline CASGoogle Scholar
• 73  Dixon MW, Peatey CL, Gardiner DL, Trenholme KR. A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum. Mol. Biochem. Parasitol.163(2),123–126 (2009).
  Medline CASGoogle Scholar
• 74  Peatey CL, Leroy D, Gardiner DL, Trenholme KR. Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? Malar. J.11,34 (2012).
  MedlineGoogle Scholar
• 75  Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen.4(2),67–73 (1999).
  Medline CASGoogle Scholar
• 76  Sui Y, Wu Z. Alternative statistical parameter for high-throughput screening assay quality assessment. J. Biomol. Screen.12(2),229–234 (2007).
  MedlineGoogle Scholar
• 77  The malera consultative group on drugs: a research agenda for malaria eradication: drugs. PLoS Medicine8(1),e1000402 (2011).
  MedlineGoogle Scholar
• 78  Mayer DC, Bruce M, Kochurova O, Stewart JK, Zhou Q. Antimalarial activity of a cis-terpenone. Malar. J.8,139 (2009).
  MedlineGoogle Scholar
• 79  Peatey CL, Skinner-Adams TS, Dixon MW, Mccarthy JS, Gardiner DL, Trenholme KR. Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J. Infect. Dis.200(10),1518–1521 (2009).
  MedlineGoogle Scholar
• 80  Peatey CL, Andrews KT, Eickel N et al. Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob. Agents Chemother.54(3),1334–1337 (2010).
  Medline CASGoogle Scholar
• 81  Vale N, Moreira R, Gomes P. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem.44(3),937–953 (2009).
  Medline CASGoogle Scholar
• 82  Delves M, Plouffe D, Scheurer C et al. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Medicine9(2),e1001169 (2012).
  MedlineGoogle Scholar
• 83  Svennas KL, Macdonald SJ, Willis PA. Small molecule anti-malarial patents: a review (January 2010-June 2011). Expert Opin. Ther. Pat.22(6),607–643 (2012).
  Medline CASGoogle Scholar
• 101  WHO: World Malaria Report (2011). www.who.int/malaria/world_malaria_report_2011/9789241564403_eng.pdf (Accessed 30 March 2012)
  Google Scholar
• 102  Malaria Elimination Gorup: Malaria-Eliminating Countries. www.malariaeliminationgroup.org/resources/elimination-countries (Accessed 26 August 2012)
  Google Scholar
• 103  Medicines for Malaria Venture: Open access Malaria Box. www.mmv.org/malariabox (Accessed 17 August 2012)
  Google Scholar
• 104  Kaneko O: origin of some P. falciparum strains (1999). www.m.ehime-u.ac.jp/school/parasitology/eng/Strain1.htm (Accessed 28 August 2012)
  Google Scholar
• 105  Malaria data. www.ebi.ac.uk/chembl/malaria (Accessed 28 August 2012)
  Google Scholar